Novo Nordisk nach Split WKN: A3EU6F ISIN: DK0062498333 Kürzel: NOV Forum: Aktien User: Coronaprofiteur
About OASIS 4 OASIS 4 was a 64-week phase 3 randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of once-daily oral semaglutide 25 mg versus placebo in 307 adults with obesity (BMI ≥ 30 kg/m2) or overweight (BMI ≥ 27 kg/m2) with one or more weight-related comorbidities.1 People with diabetes were excluded.1 OASIS 4 included a 64-week treatment period, including a 12-week dose escalation, and a 7-week off-treatment follow-up period. In total, 307 participants were randomized in a 2:1 ratio to once-daily oral semaglutide 25 mg or placebo, alongside lifestyle intervention for 64 weeks.1 For those taking Wegovy® pill, 76% achieved 5% or greater body weight loss (from a baseline body weight of 235 lb.) versus 31% taking placebo (from a baseline body weight of 231 lb.).1
About OASIS 4 OASIS 4 was a 64-week phase 3 randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of once-daily oral semaglutide 25 mg versus placebo in 307 adults with obesity (BMI ≥ 30 kg/m2) or overweight (BMI ≥ 27 kg/m2) with one or more weight-related comorbidities.1 People with diabetes were excluded.1 OASIS 4 included a 64-week treatment period, including a 12-week dose escalation, and a 7-week off-treatment follow-up period. In total, 307 participants were randomized in a 2:1 ratio to once-daily oral semaglutide 25 mg or placebo, alongside lifestyle intervention for 64 weeks.1 For those taking Wegovy® pill, 76% achieved 5% or greater body weight loss (from a baseline body weight of 235 lb.) versus 31% taking placebo (from a baseline body weight of 231 lb.).1
Mehr zu diesem Wert
|
|
Thema | ||
|---|---|---|---|
| 1 | Novo Nordisk nach Split | ||
| 2 | Novo Nordisk |
|
|
Thema | ||
|---|---|---|---|
| 1 | Ulis leckere Gerresheimer Trüffel | +3,12 % | |
| 2 | DAX Prognose / Germany 40 | -0,22 % | |
| 3 | für alle, die es ehrlich meinen beim Traden. | ||
| 4 | GERRESHEIMER Hauptdiskussion | +3,12 % | |
| 5 | HauptForum SK HYNIC | +5,32 % | |
| 6 | VONOVIA Hauptdiskussion | -2,05 % | |
| 7 | BYD Hauptdiskussion | -1,96 % | |
| 8 | DAX / Germany 40 Hauptdiskussion | -0,22 % | |
| 9 | DEUTSCHE TELEKOM Hauptdiskussion | -0,99 % | |
| 10 | Metavista3D Hauptdiskussion | +14,80 % | Alle Diskussionen |
|
|
Thema | ||
|---|---|---|---|
| 1 | Ulis leckere Gerresheimer Trüffel | +3,48 % | |
| 2 | GERRESHEIMER Hauptdiskussion | +3,48 % | |
| 3 | HauptForum SK HYNIC | +5,32 % | |
| 4 | VONOVIA Hauptdiskussion | -2,08 % | |
| 5 | BYD Hauptdiskussion | -1,99 % | |
| 6 | DEUTSCHE TELEKOM Hauptdiskussion | -0,98 % | |
| 7 | Metavista3D Hauptdiskussion | +14,80 % | |
| 8 | DRONESHIELD LTD Hauptdiskussion | +2,59 % | |
| 9 | PlasCred Circular Innovations | +0,93 % | |
| 10 | Novo Nordisk nach Split | -0,14 % | Alle Diskussionen |